Vector Laboratories Merges With Absolute Biotech, Significantly Expanding Capabilities as a Critical Component Manufacturer for Life Science Customers
May 15 2024 - 8:30AM
Business Wire
Protein detection and bioconjugation pioneer
enhances portfolio in antibody reagents while growing its
commercial footprint into the UK and EU
Vector Laboratories, a manufacturing partner of reagents and
critical components for the development and production of life
sciences tools, diagnostics, and clinical-stage biotherapeutics,
today announced its intention to merge with Absolute Biotech, a
unified company of multiple antibody-centric brands. The
transaction, which is a milestone in Vector Laboratories’
commitment to better serve life science customers, solidifies its
position as a comprehensive supplier of both custom-engineered and
catalog antibodies and sophisticated bioconjugation linkers and as
a leader in providing deep bioconjugation expertise.
Coupled with manufacturing capabilities that support small- to
large-scale projects, Vector Laboratories is poised to more
holistically support customers along their drug, diagnostic, and
life science tool development journeys. The expanded capabilities
help to reduce development time and internal resource commitments
for biopharma customers and channel partners.
“The combination with Absolute Biotech will be a tremendous
opportunity to better position Vector Laboratories as a strong
partner to biopharma and life sciences companies,” said Lisa V.
Sellers, PhD, CEO of Vector Laboratories. “For pharma and biotech
customers developing biotherapeutics, particularly antibody-drug
conjugates, it’s important that their suppliers can also provide
expert guidance in identifying the appropriate solutions to help
them succeed.”
“We also continue to see that customers – especially our life
science tools, diagnostic, and pharma customers – value the
benefits of a local presence, from timely technical and sales
support to faster delivery of products and services,” said Dr.
Sellers. “Our merger with Absolute Biotech expands our
manufacturing and distribution footprint from multiple
manufacturing sites in the US to the UK and Europe, in order to
better serve our customers across all three market segments.”
“We’re very proud of the go-to-market synergies that Absolute
Biotech brings to the table and are eager to move forward with
Vector Laboratories in supporting the researchers who are pushing
new antibodies toward the clinic,” said Heather Holemon, PhD, CEO
of Absolute Biotech. “This merger represents an ideal opportunity
to integrate our portfolio of validated, off-the-shelf and custom
antibodies with Vector’s best-in-class detection and visualization
reagents to provide an array of protein detection solutions that
support assay developers in translational and pre-clinical
research.”
Dr. Sellers will transition to CEO of the combined organization,
Vector Laboratories, Inc. Dr. Holemon will continue to drive growth
and competitive advantage as the new Chief Strategy Officer, a
critical role in shaping the future direction of the organization
and ensuring that the company remains agile and resilient in a
rapidly changing business environment.
Rebranded in 2022, Absolute Biotech is a collection of
manufacturers and suppliers that serve customers globally with
antibody reagents, kits, and services to provide annotation,
validation, sequencing, engineering, and recombinant manufacturing.
With a vision to make engineered recombinant antibodies accessible
to all, the company leverages its comprehensive antibody offering
to advance the availability of highly-defined reagents.
About Vector Labs
Vector Laboratories is a trusted reagent and critical component
manufacturing partner, empowering biopharma, life science tools,
and diagnostics companies to accelerate their ability to provide
value to their customers and ultimately address pressing healthcare
challenges. Vector Laboratories continues to expand its portfolio
of products and services, from protein and glycan detection and
visualization to bioconjugation linker and dye technologies.
Building on 45+ years of experience and an unparalleled reputation
for a culture of service, proven products, and incomparable
technical partnership, Vector Laboratories continues to invest in
areas that can support processes from discovery and development to
manufacturing and commercialization. For more information, visit
the Vector Laboratories website.
About Absolute Biotech
Absolute Biotech specializes in antibody reagents, kits, and
services, adding value to existing antibodies through annotation,
validation, sequencing, engineering, and recombinant manufacturing.
The company unites multiple antibody-centric brands to offer
customers worldwide the full breadth of antibody-related products,
services, and expertise for research, diagnostic, and therapeutic
applications. With a mission to serve as “antibody curators”
globally, Absolute Biotech delivers unique and absolutely defined
reagents that empower scientists. To learn more, visit the Absolute
Biotech website.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240515490592/en/
Kellyann Zuzulo kzuzulo@cglife.com 215-287-7291